Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liposomal Bupivacaine vs Peripheral Nerve Block

NCT03922620 is registered in ClinicalTrials.gov with Geisinger Clinic as lead sponsor.

NCT NCT03922620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03922620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liposomal Bupivacaine vs Peripheral Nerve Block
Lead sponsor
Geisinger Clinic
Phase
Phase 4
Overall status
Terminated
Start date
January 23, 2020
Completion date
June 30, 2021
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, opioid use, pain, acute, surgery